Clinical Trial Update: Intervention of Bladder Cancer by CAR-T [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a CAR-T cell therapy for bladder cancer (urothelial carcinoma of the bladder) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma of the Bladder

Drugs mentioned

• CAR-T cell therapy for bladder cancer (Chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Bladder Cancer, Urothelial Carcinoma Bladder | Phase 1, Phase 2 | Status: RECRUITING